Company: RPTX
Filing Date: 2025-08-08
Form Type: 10-Q
Source: 0000950170-25-105468
Chunk: 1

Company: Repare Therapeutics Inc.
Filing Date: 2025-08-08
Form: 10-Q
Item: Item 1
Chunk 1
---
; unlimited shares authorized as of    June 30, 2025 and December 31, 2024; 42,959,172 and 42,510,708 shares   issued and outstanding as of June 30, 2025 and December 31, 2024, respectively

     490,425

     486,674

     Warrants

     43

     10

     Additional paid-in capital

     84,533

     82,191

     Accumulated other comprehensive (loss) income

     (8
     )

     54

     Accumulated deficit

     (464,585
     )

     (417,798
     )

     Total shareholders’ equity

     110,408

     151,131

     TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY
      
     $
     130,493

     $
     176,506

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements